Q4 earnings season is still a few weeks away, with several IBD 50 firms, including Palantir stock, still in major growth mode ...

Vistra stock pulled back after reaching record highs. HubSpot stock and a travel name retreat to buy zones of bases.

Duvakitug was generally well tolerated across patient groups and showed similar rates of treatment-emergent adverse events, ...

Israel's Teva Pharmaceutical Industries and French drugmaker Sanofi said a study of a drug to treat ulcerative colitis and ...

As Merck and Roche continue to march their respective inflammatory bowel disease (IBD) assets through the clinic, Sanofi and ...

The trial was investigating the use of vagus nerve stimulation (VNS) for inflammatory bowel disease (IBD), an autoimmune ...

ORLANDO -- Major cardiovascular event risk in patients with inflammatory bowel disease (IBD) was no greater with Janus kinase ...

More than half (62.7%) of respondents reported facing financial barriers to obtaining their IBD medication.

ORLANDO -- Longer hospitalization for flares of inflammatory bowel disease (IBD) was linked to greater risk of subsequent ...

Ira Daniel Breite, MD, is a board-certified internist and gastroenterologist. He is an associate professor at the Icahn ...

The companies said Tuesday that patients with ulcerative colitis who were treated with duvakitug achieved a higher rate of clinical remission compared with a placebo group. A group of patients with ...

GET MORE AI-GENERATED SIGNALS: December 15, 2024, 01:48 am ET, BY Tom S.- Contributor| Editor: Thomas H. Kee Jr. ( Follow on ...